SEC CIK 2132179
Long Darren Marc
Reported ownership across 1 company, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| CGNXview stock → | 5,756 | 2026-08-07 |
Position History — CGNX
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — CGNX
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2026-08-07 | Option exercise (derivative) | 2,500 | $0.00 | 0 |
| 2026-08-07 | Tax withholding | 734 | $66.89 | 5,756 |
| 2026-08-07 | Option exercise | 2,500 | $0.00 | 6,490 |
| 2026-05-27 | Option exercise (derivative) | 8,675 | $0.00 | 0 |
| 2026-05-27 | Option exercise (derivative) | 5,498 | $0.00 | 11,160 |
| 2026-05-27 | Open-market sale | 1,579 | $66.52 | 3,990 |
| 2026-05-27 | Option exercise | 5,498 | $49.12 | 11,067 |
| 2026-05-27 | Option exercise | 8,675 | $51.49 | 14,244 |
| 2026-05-27 | Open-market sale | 4,500 | $66.32 | 5,569 |
| 2026-05-27 | Option exercise | 4,500 | $56.44 | 10,069 |
| 2026-04-29 | — | — | — | 5,569 |
| 2026-02-17 | Grant / award (derivative) | 11,211 | $0.00 | 11,211 |
| 2026-02-17 | Grant / award (derivative) | 7,231 | $0.00 | 7,231 |
| 2025-02-18 | Grant / award (derivative) | 9,080 | $0.00 | 9,080 |
| 2025-02-18 | Grant / award (derivative) | 31,095 | $0.00 | 31,095 |
| 2024-02-20 | Grant / award (derivative) | 3,169 | $0.00 | 3,169 |
| 2024-02-20 | Grant / award (derivative) | 34,271 | $0.00 | 34,271 |
| 2023-08-07 | Grant / award (derivative) | 2,500 | $0.00 | 2,500 |
| 2023-08-07 | Grant / award (derivative) | 23,981 | $0.00 | 23,981 |
| 2023-02-21 | Grant / award (derivative) | 20,328 | $0.00 | 20,328 |
| 2022-05-09 | Grant / award (derivative) | 16,658 | $0.00 | 16,658 |
| 2022-02-22 | Grant / award (derivative) | 10,758 | $0.00 | 10,758 |
| 2019-02-19 | Grant / award (derivative) | 8,675 | $0.00 | 8,675 |
| 2018-02-20 | Grant / award (derivative) | 4,500 | $0.00 | 4,500 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.